Acridones as antiviral agents: Synthesis, chemical and biological properties

Current Medicinal Chemistry

Volumn 20, Issue 19, 2013, Pages 2402-2414

  Sepulveda C S ^a   Fascio, M L ^b   Garcia C C ^a   D'Accorso, N B ^b   Damonte, E B ^a  

^a IQUIBICEN CONICET ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Acridones; Antiviral activity; Arenavirus; Cellular target; Flavivirus; Herpes simplex virus

Indexed keywords

1 HYDROXY 10 METHYL 9(10H) ACRIDONE; 1,3 DIHYDROXY 5 METHOXYACRIDONE; 10 ALLYL 6 CHLORO 4 METHOXY 9(10H) ACRIDONE; 10 ALLYL 6 CHLORO 9(10H) ACRIDONE; 2 FLUORO 5 METHOXY N (PYRIDINE 3 YL)ACRIDONE 4 CARBOXAMIDE; 3 ALLYLOXY 7 METHOXY 1 HYDROXYACRIDONE; 3,7 DIMETHOXY 1 HYDROXYACRIDONE; 5 CHLORO 1,3 DIHYDROXYACRIDONE; 7 AMINO 1,3 DIHYDROXY 10 METHYL 6 [4 (2 PYRIDINYL) 1 PIPERAZINYL] 9(10H) ACRIDONE; 7 AMINO 1,3 DIMETHOXY 10 METHYL 6 [4 (4 THIAZOL) 1 PIPERAZINYL] 9(10H) ACRIDONE; 7 CHLORO 1,3 DIHYDROXYACRIDONE; 7 NITRO 6 CHLORO 1,3 DIMETHOXY 10 METHYL 9(10H) ACRIDONE; ACICLOVIR; ACRIDONE DERIVATIVE; ANTIVIRUS AGENT; CITRUSININE 1; CRIDANIMOD; CYCLOFERON; DIDANOSINE; GLYCOFOLININE; N (3 METHYL 2 BUTENYL) 9(10H) ACRIDONE DERIVATIVE; N (PYRIDIN 2 YL)ACRIDONE 4 CARBOXAMIDE; N (PYRIDIN 4YL)ACRIDONE 4 CARBOXAMIDE; N CYCLOPROPYL ACRIDONE 2 THIOACETIC ACID; N CYCLOPROPYL ACRIDONE DERIVATIVE; NEVIRAPINE; S DEOXYDIHYDROGLYPARVIN; TEMACRAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CHEMICAL REACTION; CYCLIZATION; CYTOTOXICITY; DENGUE VIRUS; DNA VIRUS; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN ADENOVIRUS; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JUNIN VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; SUBSTITUTION REACTION; VIRUS REPLICATION;

ACRIDONES; ANIMALS; ANTIVIRAL AGENTS; DNA VIRUS INFECTIONS; DNA VIRUSES; HUMANS; RNA VIRUS INFECTIONS; RNA VIRUSES;

EID: 84877994798     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320190002     Document Type: Article

References (78)

1. Denny, W.A. Acridine derivatives as chemotherapeutic agents. Curr. Med. Chem., 2002, 9, 1655-1665. (Pubitemid 34947360)
2. Basco, L.K.; Mitaku, S.; Skaltsounis, A.L., Ravelomanantsoa, N.; Tillequin, F.; Koch, M.; Le Bras, J. In vitro activities of fluoroquinoline and acridone alkaloids against Plasmodium falciparum. Antimicrob. Agents Chemother., 1994, 38, 1169-1171. (Pubitemid 24150859)
3. Kelly, J.X.; Smilkstein, M.J.; Brun, R.; Wittlin, S.; Cooper, R.A.; Lane, K.D.; Janowsky, A.; Johnson, R.A.; Dodean, R.A.; Winter, R.; Hinrichs, D.J.; Riscoe, M.K. Discovery of dual function acridones as a new antimalarial chemotype. Nature, 2009, 459, 270-273.
4. Barton, V.; Fisher, N.; Biagini, G.A.; Ward, S.A.; O'Neill, P.M. Inhibiting Plasmodium Cytochrome bc1: a complex issue. Curr. Opin. Chem. Biol., 2010, 14, 440-446.
5. Valdés, A.F. Acridine and acridinones: old and new structures with antimalarial activity. Open. Med. Chem. J., 2011, 5, 11-20.
6. Fernández-Calienes, A.; Pellón, R.; Docampo, M.; Fascio, M.; D'Accorso, N.; Maes, L.; Mendiola, J.; Monzote, L.; Gille, L; Rojas, L. Antimalarial activity of new acridinone derivatives. Biomed. Pharmacother., 2011, 65, 210-214.
7. Pardo Andreu, G.L.; Inada, N.M.; Pellón, R.F.; Docampo, M.L.; Fascio, M.L.; D'Accorso, N.B.; Vercesi, A.E. New acridone derivative with trypanocidal activity. Int. J. Antimicrob. Agents, 2008, 31, 484-504.
8. Hedge, R.; Thimmaiah, P.; Yerigeri, M.C.; Krishnegowda, G.; Thimmaiah, K.N.; Houghton, P.J. Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells. Eur. J. Med. Chem., 2004, 39, 161-177. (Pubitemid 38249529)
9. Belmont, P.; Bosson, J.; Godet, T.; Tiano, M. Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now? Anticancer Agents Med. Chem., 2007, 7, 139-169. (Pubitemid 46403582)
10. Cholewinski, G.; Dzierzbicka, K.; Kolodziejczyk, A.M. Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacol. Rep., 2011, 63, 305-336.
11. Kumar, R.; Kumari, M. Chemistry of acridone and its analogues: a review. J. Chem. Pharm. Res., 2011, 3, 217-230.
12. Parikh, P.K.; Marvaniya, H.M.; Sen, D.J. Chemistry of bioactive tricyclic fused heterocyclic ring having one heteroatom. Int. J. Drug Dev. Res., 2011, 3, 44-50.
13. Giridhar, A.; Chawla, A.; Jain, S.; Jain, N.; Giridhar, S. Acridone Alkaloids-A brief review. IJPRD, 2010, 3, 44-50.
14. Pohs, G.D.; Jones W. 9(10H)-Acridone. Acta Cryst., 1995, C51, 267-268.
15. Wu, T.-S.; Furukawa, H.; Kuoh, C.-S. Constituents of Citrus depressa (Rutaceae). Characterizations of five new acridone alkaloids. Heterocycles, 1982, 19, 273-277.
16. Wu, T.-S.; Kuoh, C.-S.; Furukawa, H. Acridone alkaloids and a coumarin from Citrus grandis. Phytochemistry, 1983, 22, 1493-1497.
17. Wu T.-S., Kuoh C.-S., Furukawa H. Acridone alkaloids. VI. The constituents of Citrus depressa. Isolation and structure elucidation of new acridone alkaloids from Citrus genus. Chem. Pharm. Bull., 1983, 31, 895-900. (Pubitemid 13099308)
18. Wu T-S, Furukawa H. Acridone alkaloids. VII. Constituents of Citrus sinensis Osbeck var. brasiliensis Tanaka. Isolation and characterization of three new acridone alkaloids, and a new coumarin. Chem. Pharm. Bull., 1983, 31, 901-906. (Pubitemid 13099309)
19. Teng, W.-Y.; Huang, Y.-L.; Shen, C.-C.; Huang, R.-L.; Chung, R.-S.; Chen, C.-C. Cytotoxic acridone alkaloids from the stem bark of Citrus maxima. J. Chin. Chem. Soc., 2005, 52, 1253-1255. (Pubitemid 44028898)
20. Rastogi, K.; Kapil, R.S.; Popli, S.P. New alkaloids from Glycosmis mauritiana. Phytochemistry, 1980, 19, 945-948.
21. Chansriniyom, C.; Ruangrungsi, N.; Lipipun, V.; Kumamoto, T.; Ishikawa, T. Isolation of acridone alkaloids and N-[(4-monoterpenyloxy)phenylethyl]- substituted sulfur-containing propanamide derivatives from Glycosmis parva and their anti-herpes simplex virus activity. Chem. Pharm. Bull., 2009, 57, 1246-1250.
22. Wu, T.-S.; Kuoh, C.-S.; Furukawa, H. Acridone alkaloids from Severinia buxifolia. Phytochemistry, 1982, 21, 1771-1773.
23. Govindachari, T.R.; Viswanathan, N. Alkaloids of Atalantia monophylla correa. Tetrahedron, 1970, 26, 2905-2910.
24. Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.; Lemaire, M. Arylaryl bond formation one century after the discovery of the Ullmann reaction. Chem. Rev., 2002, 102, 1359-1470.
25. Pellón, R.F.; Docampo, M.L.; Fascio. M.L. Mild method for Ullmann reaction of 2-chlorobenzoic acids and aminothiazoles or aminobenzothiazoles under ultrasonic irradiation. Synthetic Commun., 2007, 37, 1853-1864. (Pubitemid 46911868)
26. Baqi, Y.; Müller, C.E. Rapid and efficient microwave-assisted Copper(0)-catalyzed Ullmann coupling reaction: general access to anilinoanthraquinone derivatives. Org. Lett., 2007, 9, 1271-1274.
27. Bueno, M.A.; Silva, L.R.S.P.; Corrêa, A.G. Microwave-promoted synthesis of novel N-arylanthranilic acids. J. Braz. Chem. Soc., 2008, 19, 1264-1269.
28. Pal, C; Kumar Kundu, M.; Bandyopadhyay, U.; Adhikari, S. Synthesis of novel heme-interacting acridone derivatives to prevent free heme-mediated protein oxidation and degradation. Bioorg. Med. Chem. Lett., 2011, 21, 3563-3567.
29. Stankiewicz-Drogon, A.; Palchykovska, L.G.; Kostina, V.G.; Alexeeva, I.V.; Shved, A.D.; Boguszewska-Chachulska, A.M. New acridone-4-carboxylic acid derivatives as potential inhibitors of Hepatitis C virus infection. Bioorg. Med. Chem., 2008, 16, 8846-8852.
30. Stankiewicz-Drogon, A.; Dorner, B.; Erker, T.; Boguszewska-Chachulska, A.M. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. J. Med. Chem., 2010, 53, 3117-3126.
31. Tabarrini, O.; Manfroni, G.; Fravolini, A.; Cecchetti, V.; Sabatini, S.; De Clercq, E.; Rozenski, J.; Canard, B.; Dutartre, H.; Paeshuyse, J.; Neyts, J. Synthesis and anti-BVDV activity of acridones as new potential antiviral agents. J. Med. Chem., 2006, 49, 2621-2627.
32. Tabarrini, O.; Cecchetti, V.; Fravolini, A.; Nocentini, G.; Barzi, A.; Sabatini, S.; Miao, H.; Sissi, C. Design and synthesis of modified quinolones as antitumoral acridones. J. Med. Chem., 1999, 42, 2136-2144. (Pubitemid 29284233)
33. Manfroni, G.; Paeshuyse, J.; Massari, S.; Zanoli, S.; Gatto, B.; Maga, G.; Tabarrini, O.; Cecchetti, V.; Fravolini, A.; Neyts, J. In hibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor. J. Med. Chem., 2009, 52, 3354-3365.
34. Cholody, W.M.; Hernandez, L.; Hassner, L.; Scudiero, D.A.; Djurickovic, D.B.; Michejda, C. J. Bisimidazoacridones and related compounds: new antineoplastic agents with high selectivity against colon tumors. J. Med. Chem., 1995, 38, 3043-3052.
35. Adams, J.H.; Gupta, P.; Shafig, K.M.; Lewis, J.R.; Watt, R.A. Intramolecular cyclization of 2-aminobenzophenones; a new 9-acridone synthesis. J. Chem. Soc. Perkin Trans. I, 1976, 19, 2089-2093.
36. Ning, R.Y.; Madan, P.B.; Blount, J.F.; Fryer, R.I. Structure and reactions of an unusual thionyl chloride oxidation product. 9-Chloroacridinium 2-chloro-l-(chlorosulfinyl)-2-oxoethylide. J. Org. Chem., 1976, 41, 3406-3409.
37. Turpin, J.A.; Buckheit Jr, R.W.; Derse, D.; Hollingshead, M.; Williamson, K.; Palamone, C.; Osterling, M.C.; Hill, S.A.; Graham, L.; Schaeffer, C.A.; Bu, M.; Huang, M.; Cholody, W.M.; Michejda, C.J.; Rice, W.G. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription. Antimicrob. Agents Chemother., 1998, 42, 487-494. (Pubitemid 28114797)
38. Goodell, J.R.; Madhok, A.A.; Hiasa, H.; Ferguson, D.M. Synthesis and evaluation of acridine-and acridone-based anti-herpes agents with topoisomerase activity. Bioorg. Med. Chem., 2006, 14, 5467-5480. (Pubitemid 43994481)
39. Taraporewala, I.B.; Cessac, J.W.; Chanh, T.C.; Delgado, A.V.; Schinazig, R.F. HIV-1 neutralization and tumor cell proliferation inhibition in vitro by simplified analogues of pyrido[4,3,2-mn ]thiazole [5,4-b]acridine marine alkaloids. J. Med. Chem., 1992, 35, 2744-2752.
40. Xuárez, L.; Pellón, R.F.; Fascio, M.; Montesano, V.; D'Accorso, N.B. Synthesis of N-allyl and N-propadienylacridones using phasetransfer catalysis. Heterocycles, 2004, 63, 23-28.
41. Fascio, M.L.; D'Accorso, N.B.; Pellón, R.F.; Docampo, M.L. Synthesis of novel carbohydrate acridinone derivatives with potential biological activities using 1,3-dipolar cycloaddition. Synth. Commun., 2007, 37, 4209-4217. (Pubitemid 350249174)
42. Sepúlveda, C.S.; Fascio, M.L.; Mazzucco, M.B.; Docampo Palacios, M.L.; Pellón, R.F., García, C.C.; D'Accorso, N.B.; Damonte, E.B. Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses. Antivir. Chem. Chemother., 2008, 19, 41-47.
43. Taraporewala, I.B. Thiazolo[5,4-b]acridines and thiazolo[4,5-b]acridines: probable pharmacophores of antiviral and anti-tumor marine alkaloids. Tetrahedron Lett., 1991, 32, 39-42.
44. Lowden, C.T.; Bastow, K.F. Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. J. Med. Chem., 2003, 46, 5015-5020. (Pubitemid 37352038)
45. Lowden, C.T.; Bastow, K.F. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives. Antiviral Res., 2003, 59, 143-154. (Pubitemid 36966746)
46. MacNeil, S.L.; Gray, M.; Gusev, D.G.; Briggs, L.E.; Snieckus, V. Carbanionic Friedel-Crafts equivalents. Regioselective directed ortho and remote metalation-C-N cross coupling routes to acridones and dibenzo[b,f]azepinones. J. Org. Chem., 2008, 73, 9710-9719.
47. Zhao, J.; Larock, R.C. Synthesis of xanthones, thioxanthones, and acridones by the coupling of arynes and substituted benzoates. J. Org. Chem., 2007, 72, 583-588. (Pubitemid 46106519)
48. Fang, Y.; Rogness, D.C.; Larock, R.C.; Shi, F. Formation of acridones by ethylene extrusion in the reaction of arynes with-lactams and dihydroquinolinones. J. Org. Chem., 2012, 77, 6262 6270.
49. Kim, J.; Stoltz, B.M. A C-N insertion of-lactam to benzyne: unusual formation of acridone. Tetrahedron Lett., 2012, 53, 4994-4996.
50. Whitley, R.J.; Roizman, B. In: Clinical Virology; Richmann, D.D.; Whitley, R.J.; Hayden, F.G., Ed.; ASM Press:Washington, 2009; pp. 409-436.
51. Littler, E.; Oberg, B. Achievements and challenges in antiviral drug discovery. Antiviral Chem. Chemother., 2005, 16, 155-168. (Pubitemid 41512157)
52. Piret, J.; Boivin, G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence and management. Antimicrob. Agents Chemother., 2011, 55, 459-472.
53. Kleymann, G. Agents and strategies in development for improved management of herpes simplex virus infection and disease. Expert Opin. Investig. Drugs, 2005, 14, 135-161. (Pubitemid 40403389)
54. Eizuru, Y. Development of new antivirals for herpesviruses. Antiviral Chem. Chemother., 2003, 14, 299-308. (Pubitemid 38166090)
55. Yamamoto, N.; Furukawa, H.; Ito, Y.; Yoshida, S.; Maeno, K.; Nishiyama, Y. Anti-herpesvirus activity of citrusinine-I, a new acridone alkaloid, and related compounds. Antiviral Res., 1989, 12, 21-36. (Pubitemid 19214664)
56. Takemura, Y.; Ju-ichi, M.; Ito, C., Furukawa, H.; Tokuda, H. Studies on the inhibitory effects of some acridone alkaloids on Epstein-Barr virus activation. Planta Med., 1995, 61, 366-368.
57. Itoigawa, M.; Ito, C.; Wu, T.-S.; Enjo, F.; Tozuda, H.; Nishino, H.; Furukawa, H. Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett., 2003, 193, 133-138. (Pubitemid 36428894)
58. Akanitapichat, P.; Lowden, C.T.; Bastow, K.F. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication. Antiviral Res., 2000, 45, 123-134. (Pubitemid 30156781)
59. Akanitapichat, P.; Bastow, K.F. The antiviral agent 5-chloro-1,3- dihydroxyacridone interferes with assembly and maturation of herpes simplex virus. Antiviral Res., 2002, 53, 113-126. (Pubitemid 34065301)
60. Storch, E.; Kirchner, H.; Brehm, G.; Huller, K.; Marcucci, F. Production of interferon-beta by murine T-cell lines induced by 10-carboxymethyl-9- acridanone. Scand. J. Immunol. 1986, 23, 195-199. (Pubitemid 16169558)
61. Zarubaev, V.V.; Slita, A.V.; Krivitskaya, V.Z.; Sirotkin, A.K.; Kovalenko, A.L.; Chatterjee, N.K. Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res., 2003, 58, 131-137. (Pubitemid 36556216)
62. Fujiwara, M.; Okamoto, M.; Okamoto, M.; Watanabe, M.; Machida, H.; Shigeta, S.; Konno, K.; Yokota, T.; Baba, M. Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells. Antiviral Res., 1999, 43, 189-199. (Pubitemid 29457440)
63. Houe, H. Economic impact of BVDV infection in dairies. Biologicals, 2003, 31, 137-143. (Pubitemid 36593351)
64. El-Serag, H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 2012, 142, 1264-1273.
65. Raney, K.D.; Sharma, S.D.; Moustafa, I.M.; Cameron, C.E. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target. J. Biol. Chem., 2010, 285, 22725-22731.
66. Hayashi, N.; Takehara, T. Antiviral therapy for chronic hepatitis C: past, present and future. J. Gastroenterol., 2006, 41, 17-27.
67. Kyle, J.L.; Harris, E. Global spread and persistence of dengue. Annu. Rev. Microbiol., 2008, 62, 71-92.
68. García, C.C.; Sepúlveda, C.S.; Damonte, E.B. Novel therapeutic targets for arenavirus hemorrhagic fevers. Future Virol., 2011, 6, 27-44.
69. Adams, A. Crystal structures of acridines complexed with nucleic acids. Curr. Med. Chem., 2002, 9, 1667-1675. (Pubitemid 34947361)
70. Ebert, S.N.; Shtrom, S.S.; Muller, M.T. Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent. J. Virol., 1990, 64, 4059-4066. (Pubitemid 20279810)
71. Ebert, S.N.; Subramanian, D.; Shtrom, S.S.; Chung, I.K.; Parris, D.S.; Muller, M.T. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. J. Virol., 1994, 68, 1010-1020. (Pubitemid 24022205)
72. González-Molleda, L.; Wang, Y.; Yuan, Y. Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcomaassociated herpesvirus. Antimicrob. Agents Chemother., 2012, 56, 893-902.
73. Kovalenko, A.L.; Kazakov, V.I.; Slita, A.V.; Zarubaev, V.V.; Sukhinin, V.P. Intracellular localization of cycloferon, its binding with DNA and stimulation of cytokines expression after exposure to cycloferon. Tsitologiia, 2000, 42, 659-664.
74. Bastow KF, Itoigawa M, Furukawa H, Kashiwada Y, Bori ID, Ballas LM, Lee KH. Antiproliferative actions of 7-substituted 1,3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targets. Bioorg. Med. Chem., 1994, 2, 1403-1411.
75. Watterson, S.H.; Chen, P.; Zhao, Y; Gu, H.H.; Dhar, T.G.; Xiao, Z; Ballentine, S.K.; Shen, Z.; Fleener, C.A.; Rouleau, K.A.; Obermeier, M.; Yang, Z.; McIntyre, K.W.; Shuster, D.J.; Witmer, M.; Dambach, D.; Chao, S.; Mathur, A.; Chen, B.C.; Barrish, J.C.; Robl, J.A.; Townsend, R.; Iwanowicz, E.J. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin- 3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419). J. Med. Chem., 2007, 50, 3730-3742. (Pubitemid 47195479)
76. Nair, V.; Shu, Q. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir. Chem. Chemother., 2007, 18, 245-258. (Pubitemid 350220744)
77. Sepúlveda, C.S.; García, C.C.; Fascio, M.L.; D'Accorso, N.B.; Docampo Palacios, M.L.; Pellón, R.F.; Damonte, E.B. Inhibition of Junin virus RNA synthesis by an antiviral acridone derivative. Antiviral Res., 2012, 93, 16-22.
78. Bastow, K.F. New acridone inhibitors of human herpes virus replication. Curr. Drug Targets Infect. Disord., 2002, 4, 323-330.